These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 11838726
1. Transposition of the thyroid iodide uptake and organification system in nonthyroid tumor cells by adenoviral vector-mediated gene transfers. Boland A, Magnon C, Filetti S, Bidart JM, Schlumberger M, Yeh P, Perricaudet M. Thyroid; 2002 Jan; 12(1):19-26. PubMed ID: 11838726 [Abstract] [Full Text] [Related]
2. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. Boland A, Ricard M, Opolon P, Bidart JM, Yeh P, Filetti S, Schlumberger M, Perricaudet M. Cancer Res; 2000 Jul 01; 60(13):3484-92. PubMed ID: 10910060 [Abstract] [Full Text] [Related]
3. Combining transfer of TTF-1 and Pax-8 gene: a potential strategy to promote radioiodine therapy of thyroid carcinoma. Mu D, Huang R, Li S, Ma X, Lou C, Kuang A. Cancer Gene Ther; 2012 Jun 01; 19(6):402-11. PubMed ID: 22498723 [Abstract] [Full Text] [Related]
4. Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer. Huang M, Batra RK, Kogai T, Lin YQ, Hershman JM, Lichtenstein A, Sharma S, Zhu LX, Brent GA, Dubinett SM. Cancer Gene Ther; 2001 Aug 01; 8(8):612-8. PubMed ID: 11571539 [Abstract] [Full Text] [Related]
5. Cotransfected sodium iodide symporter and human tyroperoxidase genes following human telomerase reverse transcriptase promoter for targeted radioiodine therapy of malignant glioma cells. Li W, Tan J, Wang P, Wu P. Cancer Biother Radiopharm; 2011 Aug 01; 26(4):443-51. PubMed ID: 21797672 [Abstract] [Full Text] [Related]
6. Adenovirus-mediated transfer of thyroid transcription factor-1 induces radioiodide organification and retention in thyroid cancer cells. Furuya F, Shimura H, Miyazaki A, Taki K, Ohta K, Haraguchi K, Onaya T, Endo T, Kobayashi T. Endocrinology; 2004 Nov 01; 145(11):5397-405. PubMed ID: 15271884 [Abstract] [Full Text] [Related]
7. Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene. Shimura H, Haraguchi K, Miyazaki A, Endo T, Onaya T. Endocrinology; 1997 Oct 01; 138(10):4493-6. PubMed ID: 9322970 [Abstract] [Full Text] [Related]
10. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Eng PH, Cardona GR, Fang SL, Previti M, Alex S, Carrasco N, Chin WW, Braverman LE. Endocrinology; 1999 Aug 01; 140(8):3404-10. PubMed ID: 10433193 [Abstract] [Full Text] [Related]
11. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter. Dwyer RM, Bergert ER, O'connor MK, Gendler SJ, Morris JC. Clin Cancer Res; 2005 Feb 15; 11(4):1483-9. PubMed ID: 15746050 [Abstract] [Full Text] [Related]
12. Iodination of proteins in TPO transfected thyroid cancer cells is independent of NIS. Wenzel A, Upadhyay G, Schmitt TL, Loos U. Mol Cell Endocrinol; 2003 Dec 31; 213(1):99-108. PubMed ID: 15062578 [Abstract] [Full Text] [Related]
13. Telomerase reverse transcriptase promoter-driven expression of iodine pump genes for targeted radioiodine therapy of malignant glioma cells. Tan J, Li W, Wang P. Chin J Cancer; 2011 Aug 31; 30(8):574-80. PubMed ID: 21801606 [Abstract] [Full Text] [Related]
14. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma. Ma XJ, Huang R, Kuang AR. Cancer Invest; 2009 Jul 31; 27(6):673-81. PubMed ID: 19241193 [Abstract] [Full Text] [Related]
15. The rat sodium iodide symporter gene permits more effective radioisotope concentration than the human sodium iodide symporter gene in human and rodent cancer cells. Heltemes LM, Hagan CR, Mitrofanova EE, Panchal RG, Guo J, Link CJ. Cancer Gene Ther; 2003 Jan 31; 10(1):14-22. PubMed ID: 12489024 [Abstract] [Full Text] [Related]
16. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy. Mitrofanova E, Unfer R, Vahanian N, Link C. Gene Ther; 2006 Jul 31; 13(13):1052-6. PubMed ID: 16525480 [Abstract] [Full Text] [Related]
17. Retinoic acid modulation of thyroid dual oxidase activity in rats and its impact on thyroid iodine organification. Mühlbauer M, da Silva AC, Marassi MP, Lourenço AL, Ferreira AC, de Carvalho DP. J Endocrinol; 2010 Jun 31; 205(3):271-7. PubMed ID: 20212023 [Abstract] [Full Text] [Related]
18. Follicular thyroglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide symporter gene. Suzuki K, Mori A, Saito J, Moriyama E, Ullianich L, Kohn LD. Endocrinology; 1999 Nov 31; 140(11):5422-30. PubMed ID: 10537174 [Abstract] [Full Text] [Related]
19. [Study on the iodine 125 uptake of H460 lung cancer cell line by co-transfection with the human sodium/iodide symporter and the human thyroperoxidase]. Li W, Tan J, Long L. Zhongguo Fei Ai Za Zhi; 2010 Jun 31; 13(6):575-9. PubMed ID: 20681442 [Abstract] [Full Text] [Related]
20. Histone deacetylase inhibitors restore radioiodide uptake and retention in poorly differentiated and anaplastic thyroid cancer cells by expression of the sodium/iodide symporter thyroperoxidase and thyroglobulin. Furuya F, Shimura H, Suzuki H, Taki K, Ohta K, Haraguchi K, Onaya T, Endo T, Kobayashi T. Endocrinology; 2004 Jun 31; 145(6):2865-75. PubMed ID: 14976143 [Abstract] [Full Text] [Related] Page: [Next] [New Search]